Back
Leap Therapeutics Stock Price Chart
Sponsored
LPTX
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Buy
63
LPTX
Leap Therapeutics
Last Price:
3.23
Seasonality Move:
-4.93%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LPTX is experiencing slight buying pressure.
Leap Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.18 | Buy |
20-day SMA: | 3.1 | Buy |
50-day SMA: | 2.78 | Buy |
200-day SMA: | 2.51 | Buy |
8-day EMA: | 3.16 | Buy |
20-day EMA: | 3.06 | Buy |
50-day EMA: | 2.93 | Buy |
200-day EMA: | 3.22 | Sell |
Leap Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 55.61 | Buy |
Chaikin Money Flow: | 111531 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.74 - 3.26) | Buy |
Bollinger Bands (100): | (2.53 - 3.57) | Buy |
Leap Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Leap Therapeutics Stock
Is Leap Therapeutics Stock a Buy?
- Leap Therapeutics share price is 3.19 while LPTX 8-day simple moving average is 3.18, which is a Buy signal.
- The stock price of LPTX is 3.19 while Leap Therapeutics 20-day SMA is 3.10, which makes it a Buy.
- Leap Therapeutics 50-day simple moving average is 2.78 while LPTX share price is 3.19, making it a Buy technically.
- LPTX stock price is 3.19 and Leap Therapeutics 200-day simple moving average is 2.51, creating a Buy signal.
LPTX Technical Analysis vs Fundamental Analysis
Buy
63
Leap Therapeutics (LPTX)
is a Buy
Is Leap Therapeutics a Buy or a Sell?
-
Leap Therapeutics stock is rated a Buy
The current Leap Therapeutics [LPTX] share price is $3.19. The Score for LPTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Leap Therapeutics Stock Info
Market Cap:
81.66M
Price in USD:
3.19
Share Volume:
334.59K
Leap Therapeutics 52-Week Range
52-Week High:
10.20
52-Week Low:
1.24
Buy
63
Leap Therapeutics (LPTX)
is a Buy
Leap Therapeutics Share Price Forecast
-
What is the Leap Therapeutics stock price today?
The Leap Therapeutics stock price is 3.19 USD today. -
Will LPTX stock go up or go down?
Leap Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Leap Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Leap Therapeutics is not overvalued.
Is Leap Therapeutics Stock a Buy?
- Leap Therapeutics share price is 3.19 while LPTX 8-day exponential moving average is 3.16, which is a Buy signal.
- The stock price of LPTX is 3.19 while Leap Therapeutics 20-day EMA is 3.06, which makes it a Buy.
- Leap Therapeutics 50-day exponential moving average is 2.93 while LPTX share price is 3.19, making it a Buy technically.
- LPTX stock price is 3.19 and Leap Therapeutics 200-day simple moving average is 3.22, creating a Sell signal.
Fundamental Analysis of Leap Therapeutics
Is Leap Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.26 per share, an increase this year of $1.00 per share, and an increase next year of $0.91 per share.
Technical Analysis of Leap Therapeutics
Should I short Leap Therapeutics stock?
- LPTX Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Leap Therapeutics is a Buy
- Leap Therapeutics Relative Strength Index (RSI) is 55.61, which suggest Leap Therapeutics is overbought
- The Bollinger Bands (25) for Leap Therapeutics is (2.74 - 3.26), which suggest Leap Therapeutics is a Buy
- The Bollinger Bands (100) for Leap Therapeutics is (2.53 - 3.57), which suggest Leap Therapeutics is a Buy
* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.